Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.86+0.02 (+1.09%)
Close on Nov 13, 2026Market cap $5.20MP/E –Yield –
Processa Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Processa Pharmaceuticals's enterprise value was $5.03M on Nov 11, 2026, against $7.38M a year earlier. Over the last 5 years it ranged from -$4.69M to $57.34M, with a median of $1.38M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.03M | – |
| 2025 | Dec 31, 2025 | -$218.61K | – |
| 2024 | Dec 31, 2024 | -$4.13K | -100.3% |
| 2023 | Dec 29, 2023 | $1.38M | -83.6% |
| 2022 | Dec 30, 2022 | $8.43M | -85.3% |
| 2021 | Dec 31, 2021 | $57.34M | +52.1% |
| 2020 | Dec 31, 2020 | $37.70M | -61.6% |
| 2019 | Dec 31, 2019 | $98.25M | -28.2% |
| 2018 | Dec 31, 2018 | $136.81M | -52.6% |
| 2017 | Dec 29, 2017 | $288.67M | +461.5% |
| 2016 | Dec 30, 2016 | $51.41M | -37.5% |
| 2015 | Dec 31, 2015 | $82.25M | -76.3% |
| 2014 | Dec 31, 2014 | $346.31M | – |
See a number that looks wrong?